Diebold Nixdorf, Incorporated
DBD · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $945 | $915 | $841 | $989 |
| % Growth | 3.3% | 8.8% | -14.9% | – |
| Cost of Goods Sold | $697 | $681 | $639 | $753 |
| Gross Profit | $248 | $234 | $202 | $236 |
| % Margin | 26.2% | 25.6% | 24.1% | 23.9% |
| R&D Expenses | $20 | $22 | $23 | $26 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $148 | $145 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $154 | $8 | $5 | $170 |
| Operating Expenses | $174 | $178 | $173 | $195 |
| Operating Income | $74 | $56 | $30 | $41 |
| % Margin | 7.8% | 6.1% | 3.5% | 4.2% |
| Other Income/Exp. Net | -$23 | -$39 | -$39 | -$29 |
| Pre-Tax Income | $51 | $18 | -$10 | $12 |
| Tax Expense | $10 | $5 | -$2 | $6 |
| Net Income | $41 | $12 | -$8 | $6 |
| % Margin | 4.3% | 1.3% | -1% | 0.6% |
| EPS | 1.1 | 0.33 | -0.22 | 0.15 |
| % Growth | 233.3% | 250% | -246.7% | – |
| EPS Diluted | 1.09 | 0.33 | -0.22 | 0.15 |
| Weighted Avg Shares Out | 37 | 37 | 38 | 38 |
| Weighted Avg Shares Out Dil | 38 | 38 | 38 | 38 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $3 | $2 | $2 |
| Interest Expense | $22 | $22 | $22 | $35 |
| Depreciation & Amortization | $32 | $31 | $34 | $43 |
| EBITDA | $105 | $70 | $48 | $132 |
| % Margin | 11.1% | 7.7% | 5.7% | 13.4% |